Tickerplace logo

Tickerplace

Apogee Therapeutics, Inc. logo

APGEApogee Therapeutics, Inc.

APGE Stock Price, Valuation & Chart | Apogee Therapeutics, Inc.

Compare
$135.07+0.00 (+0.00%)

At close · 04 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

APGE Historical price chart

APGE Key Stats

Market Capitalization8.40B
PE Ratio-31.19
EPS-4.33
Trading Volume4.97M
Today's High/Low135.07/135.07
Dividend Yield0.00
52 Week High/Low135.09/35.39
Shares Outstanding62.20M
APGE Financial Statement
APGE Analyst ratings
APGE Analysis & performance metrics

APGE Company profile

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic…

APGE Management team

Management
Drew Badger Ph.D.
Senior Vice President and Head of Regulatory Affairs & Toxicology
Emily Cox
SVice President & Head of People
Wendy Aspden-Curran
Senior Vice President of Clinical Operations
Michael Thomas Henderson M.D.CEO
Chief Executive Officer & Director
Jane Pritchett V. HendersonCFO
Chief Financial Officer
Noel Kurdi
Vice President of Investor Relations
Monica Forbes
Senior Vice President of Finance
Carl Linden Dambkowski M.D.
Chief Medical Officer
Total 8 executives

APGE Frequently asked questions

What is Apogee Therapeutics, Inc. (APGE) Stock Price?

Current stock price of Apogee Therapeutics, Inc. (APGE) stock is $135.07. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Apogee Therapeutics, Inc. (APGE) stock is 4.97M.

Last updated at 04 Sept 2026, 08:00 pm.

Why is the Apogee Therapeutics, Inc. (APGE) stock price going up or down today?

The stock price of Apogee Therapeutics, Inc. (APGE) can change with earnings, company news, and overall market sentiment. Apogee Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Apogee Therapeutics, Inc. stock expensive at its current price?

Whether Apogee Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for APGE on this page is -31.19. EPS on this page is -4.33. Compare those figures with peers and growth expectations before deciding if the current Apogee Therapeutics, Inc. price is justified.

How has the stock price of Apogee Therapeutics, Inc. (APGE) performed historically?

Historical performance for Apogee Therapeutics, Inc. (APGE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how APGE reacted to past earnings and market events.

Should I buy Apogee Therapeutics, Inc. (APGE) stock, at this price?

Buying Apogee Therapeutics, Inc. (APGE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.